Homology Class Action: Levi & Korsinsky Reminds Homology Medicines, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of May 24, 2022 – FIXX

New York, New York–(Newsfile Corp. – May 9, 2022) – Levi & Korsinsky, LLP notifies investors in Homology Medicines, Inc. (“Homology” or the “Company”) (NASDAQ: FIXX) of a class action securities lawsuit.The lawsuit on behalf of Homology investors has been commenced in the the United States District Court for the Central District of California. Affected investors purchased or otherwise acquired certain Homology Medicines, Inc. securities between June 10, 2019 and February 18, 2022. Follow the…